mofezolac has been researched along with Gastric Ulcer in 1 studies
mofezolac: Cyclooxygenase 1 inhibitor; structure in first source; RN from Toxlit
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mofezolac (N-22) is a new developed analgesic and anti-inflammatory agent." | 1.28 | [Three-month subacute oral toxicity study of mofezolac (N-22) in dogs]. ( Iwata, M; Kiguchi, M; Nasu, Y; Shimpo, K; Takeuchi, M; Yada, H; Yamashita, K, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimpo, K | 1 |
| Takeuchi, M | 1 |
| Kiguchi, M | 1 |
| Iwata, M | 1 |
| Nasu, Y | 1 |
| Yada, H | 1 |
| Yamashita, K | 1 |
1 other study available for mofezolac and Gastric Ulcer
| Article | Year |
|---|---|
[Three-month subacute oral toxicity study of mofezolac (N-22) in dogs].
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Proteins; Body Weight; | 1990 |